TEVA.TA
Teva Pharmaceutical Industries Ltd
Price:  
6,202.00 
USD
Volume:  
2,234,908.00
Israel | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TEVA.TA Fair Value

-109.04 %
Upside

What is the fair value of TEVA.TA?

As of 2025-05-14, the Fair Value of Teva Pharmaceutical Industries Ltd (TEVA.TA) is -560.73 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6,202.00 USD, the upside of Teva Pharmaceutical Industries Ltd is -109.04%.

Is TEVA.TA a good investment?

With the market price of 6,202.00 USD and our fair value calculation, Teva Pharmaceutical Industries Ltd (TEVA.TA) is not a good investment. Investing in TEVA.TA stocks now will result in a potential loss of 109.04%.

Note: valuation result may not be accurate due to the company's negative EPS.

6,202.00 USD
Stock Price
-560.73 USD
Fair Price
FAIR VALUE CALCULATION

TEVA.TA Fair Value

Peter Lynch's formula is:

TEVA.TA Fair Value
= Earnings Growth Rate x TTM EPS
TEVA.TA Fair Value
= 5.00 x -112.14
TEVA.TA Fair Value
= -560.73

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -3,991.00 417.00 -2,446.00 -559.00 -1,639.00 -1,643.60
YoY growth -299.90% 110.45% -686.57% 77.15% -193.20% -198.42%

TEVA.TA Fair Value - Key Data

Market Cap (mil) 71,065.00
P/E
Forward P/E
EPS -112.14
Avg earnings growth rate -198.42%
TTM earnings -1,285.00